{"assetProfile": {"address1": "Carl Jacobsens Vej 30", "address2": "Valby", "city": "Copenhagen", "zip": "2500", "country": "Denmark", "phone": "45 70 20 27 28", "website": "https://www.genmab.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark. The company markets EPKINLY and TEPKINLY for adult patients with relapsed or refractory (R/R) diffuse large b-cell lymphoma (DLBCL), large Bcell lymphoma, and follicular lymphoma (FL); and Tivdak for adult patients with recurrent/metastatic cervical cancer with disease progression on or after chemotherapy. It is also developing Epcoritamab for R/R DLBCL and FL, first line DLBCL and FL, B-cell non-Hodgkin lymphoma, R/R chronic lymphocytic leukemia and Richter's syndrome, and aggressive mature B-cell neoplasms in pediatric patients; tisotumab vedotin for solid tumors; Acasunlimab for solid tumors and non-small cell lung cancer (NSCLC); Rinatabart Sesutecan for platinum resistant ovarian cancer and solid tumors; GEN1042, GEN1059, GEN1055, and GEN1057 for solid tumors; GEN3014 for hematologic malignancies; GEN1160 for advanced solid and liquid tumors; and GEN1107 and GEN1286 for advanced solid tumors. In addition, the company offers DARZALEX/DARZALEX FASPRO for multiple myeloma (MM) and light-chain Amyloidosis; RYBREVANT for NSCLC; TECVAYLI and TALVEY for R/R MM; Kesimpta for Relapsing multiple sclerosis; and TEPEZZA for thyroid eye disease. Further, it is developing Amivantamab for recurrent/metastatic head and neck cancer, and advanced or metastatic colorectal cancer; Amlenetug for multiple system atrophy; Inclacumab for vaso-occulsive crises in sickle cell diseases; and Mim8 for hemophilia A. The company has a collaboration agreement with AbbVie Inc., Pfizer Inc., BioNTech SE, Johnson & Johnson, Novartis International AG, Medarex, Inc., ADC Therapeutics SA, Bristol Myers Squibb Corporation, Lundbeck A/S, Amgen Inc., Immatics, Novo Nordisk A/S, CureVac AG, and argenx. Genmab A/S was incorporated in 1998 and is headquartered in Copenhagen, Denmark.", "fullTimeEmployees": 2639, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jan G.J. van de Winkel Ph.D.", "age": 63, "title": "Co-Founder, President & CEO", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": {"raw": 3148169, "fmt": "3.15M", "longFmt": "3,148,169"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Anthony  Pagano CPA", "age": 46, "title": "Executive VP & CFO", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": {"raw": 1157415, "fmt": "1.16M", "longFmt": "1,157,415"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Rayne  Waller", "age": 56, "title": "Executive VP & Chief Technical Operations Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": {"raw": 783956, "fmt": "783.96k", "longFmt": "783,956"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Christopher  Cozic", "age": 46, "title": "Executive VP & Chief People Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": {"raw": 848771, "fmt": "848.77k", "longFmt": "848,771"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Martine J. van Vugt Ph.D.", "age": 53, "title": "Executive VP & Chief Strategy Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": {"raw": 802474, "fmt": "802.47k", "longFmt": "802,474"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Martin  Schultz", "age": 49, "title": "Senior Director, Head of Development Business Partnership & Strategy and Director", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": {"raw": 216051, "fmt": "216.05k", "longFmt": "216,051"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Judith V. Klimovsky M.D.", "age": 66, "title": "Executive VP & Chief Development Officer", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": {"raw": 1311737, "fmt": "1.31M", "longFmt": "1,311,737"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Tahamtan  Ahmadi M.D., Ph.D.", "age": 52, "title": "Executive VP, Chief Medical Officer & Head of Experimental Medicines", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": {"raw": 1219144, "fmt": "1.22M", "longFmt": "1,219,144"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Mijke  Zachariasse Ph.D.", "age": 51, "title": "VP, Head of Antibody Research Materials & Director", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": {"raw": 246915, "fmt": "246.91k", "longFmt": "246,915"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Takahiro  Hamatani", "age": 49, "title": "Senior Director of Finance Japan & Non-Independent Director", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": {"raw": 216051, "fmt": "216.05k", "longFmt": "216,051"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.genmab.com/index.cfm", "executiveTeam": [], "maxAge": 86400}, "calendarEvents": {"maxAge": 1, "earnings": {"earningsDate": [{"raw": 1762462800, "fmt": "2025-11-06"}], "earningsCallDate": [{"raw": 1762448400, "fmt": "2025-11-06"}], "isEarningsDateEstimate": false, "earningsAverage": {"raw": 0.45395, "fmt": "0.45"}, "earningsLow": {"raw": 0.414, "fmt": "0.41"}, "earningsHigh": {"raw": 0.47786, "fmt": "0.48"}, "revenueAverage": {"raw": 6373437550, "fmt": "6.37B", "longFmt": "6,373,437,550"}, "revenueLow": {"raw": 5945216000, "fmt": "5.95B", "longFmt": "5,945,216,000"}, "revenueHigh": {"raw": 6702079000, "fmt": "6.7B", "longFmt": "6,702,079,000"}}, "exDividendDate": {}, "dividendDate": {}}, "earningsTrend": {"trend": [{"maxAge": 1, "period": "0q", "endDate": "2025-09-30", "growth": {"raw": 0.59220004, "fmt": "59.22%"}, "earningsEstimate": {"avg": {"raw": 0.45395, "fmt": "0.45"}, "low": {"raw": 0.414, "fmt": "0.41"}, "high": {"raw": 0.47786, "fmt": "0.48"}, "yearAgoEps": {"raw": 0.28511, "fmt": "0.29"}, "numberOfAnalysts": {"raw": 3, "fmt": "3", "longFmt": "3"}, "growth": {"raw": 0.59220004, "fmt": "59.22%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 6373437550, "fmt": "6.37B", "longFmt": "6,373,437,550"}, "low": {"raw": 5945216000, "fmt": "5.95B", "longFmt": "5,945,216,000"}, "high": {"raw": 6702079000, "fmt": "6.7B", "longFmt": "6,702,079,000"}, "numberOfAnalysts": {"raw": 11, "fmt": "11", "longFmt": "11"}, "yearAgoRevenue": {"raw": 5540000000, "fmt": "5.54B", "longFmt": "5,540,000,000"}, "growth": {"raw": 0.1504, "fmt": "15.04%"}, "revenueCurrency": "DKK"}, "epsTrend": {"current": {"raw": 0.45395, "fmt": "0.45"}, "7daysAgo": {"raw": 0.44593, "fmt": "0.45"}, "30daysAgo": {"raw": 0.45129, "fmt": "0.45"}, "60daysAgo": {"raw": 0.4369, "fmt": "0.44"}, "90daysAgo": {"raw": 0.43469, "fmt": "0.43"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "upLast30days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast30days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast7Days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}, {"maxAge": 1, "period": "+1q", "endDate": "2025-12-31", "growth": {"raw": -0.517, "fmt": "-51.70%"}, "earningsEstimate": {"avg": {"raw": 0.40334, "fmt": "0.4"}, "low": {"raw": 0.24603, "fmt": "0.25"}, "high": {"raw": 0.524, "fmt": "0.52"}, "yearAgoEps": {"raw": 0.83506, "fmt": "0.84"}, "numberOfAnalysts": {"raw": 3, "fmt": "3", "longFmt": "3"}, "growth": {"raw": -0.517, "fmt": "-51.70%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 6604754450, "fmt": "6.6B", "longFmt": "6,604,754,450"}, "low": {"raw": 6219190000, "fmt": "6.22B", "longFmt": "6,219,190,000"}, "high": {"raw": 7376212000, "fmt": "7.38B", "longFmt": "7,376,212,000"}, "numberOfAnalysts": {"raw": 9, "fmt": "9", "longFmt": "9"}, "yearAgoRevenue": {"raw": 6441000000, "fmt": "6.44B", "longFmt": "6,441,000,000"}, "growth": {"raw": 0.0254, "fmt": "2.54%"}, "revenueCurrency": "DKK"}, "epsTrend": {"current": {"raw": 0.40334, "fmt": "0.4"}, "7daysAgo": {"raw": 0.38502, "fmt": "0.39"}, "30daysAgo": {"raw": 0.39834, "fmt": "0.4"}, "60daysAgo": {"raw": 0.36675, "fmt": "0.37"}, "90daysAgo": {"raw": 0.15124, "fmt": "0.15"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "upLast30days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast30days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast7Days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}, {"maxAge": 1, "period": "0y", "endDate": "2025-12-31", "growth": {"raw": -0.0153, "fmt": "-1.53%"}, "earningsEstimate": {"avg": {"raw": 1.71426, "fmt": "1.71"}, "low": {"raw": 1.53402, "fmt": "1.53"}, "high": {"raw": 1.79, "fmt": "1.79"}, "yearAgoEps": {"raw": 1.74087, "fmt": "1.74"}, "numberOfAnalysts": {"raw": 4, "fmt": "4", "longFmt": "4"}, "growth": {"raw": -0.0153, "fmt": "-1.53%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 23692094460, "fmt": "23.69B", "longFmt": "23,692,094,460"}, "low": {"raw": 22957591620, "fmt": "22.96B", "longFmt": "22,957,591,620"}, "high": {"raw": 25255000000, "fmt": "25.25B", "longFmt": "25,255,000,000"}, "numberOfAnalysts": {"raw": 18, "fmt": "18", "longFmt": "18"}, "yearAgoRevenue": {"raw": 21526000000, "fmt": "21.53B", "longFmt": "21,526,000,000"}, "growth": {"raw": 0.100600004, "fmt": "10.06%"}, "revenueCurrency": "DKK"}, "epsTrend": {"current": {"raw": 1.71426, "fmt": "1.71"}, "7daysAgo": {"raw": 1.66901, "fmt": "1.67"}, "30daysAgo": {"raw": 1.68326, "fmt": "1.68"}, "60daysAgo": {"raw": 1.733, "fmt": "1.73"}, "90daysAgo": {"raw": 1.3431, "fmt": "1.34"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 0, "fmt": null, "longFmt": "0"}, "upLast30days": {"raw": 2, "fmt": "2", "longFmt": "2"}, "downLast30days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast7Days": {"raw": 0, "fmt": null, "longFmt": "0"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}, {"maxAge": 1, "period": "+1y", "endDate": "2026-12-31", "growth": {"raw": -0.34669998, "fmt": "-34.67%"}, "earningsEstimate": {"avg": {"raw": 1.1199, "fmt": "1.12"}, "low": {"raw": 0.44, "fmt": "0.44"}, "high": {"raw": 1.82858, "fmt": "1.83"}, "yearAgoEps": {"raw": 1.71426, "fmt": "1.71"}, "numberOfAnalysts": {"raw": 4, "fmt": "4", "longFmt": "4"}, "growth": {"raw": -0.34669998, "fmt": "-34.67%"}, "earningsCurrency": "USD"}, "revenueEstimate": {"avg": {"raw": 27157946540, "fmt": "27.16B", "longFmt": "27,157,946,540"}, "low": {"raw": 25272385000, "fmt": "25.27B", "longFmt": "25,272,385,000"}, "high": {"raw": 29478198000, "fmt": "29.48B", "longFmt": "29,478,198,000"}, "numberOfAnalysts": {"raw": 16, "fmt": "16", "longFmt": "16"}, "yearAgoRevenue": {"raw": 23692094460, "fmt": "23.69B", "longFmt": "23,692,094,460"}, "growth": {"raw": 0.1463, "fmt": "14.63%"}, "revenueCurrency": "DKK"}, "epsTrend": {"current": {"raw": 1.1199, "fmt": "1.12"}, "7daysAgo": {"raw": 1.45653, "fmt": "1.46"}, "30daysAgo": {"raw": 1.75614, "fmt": "1.76"}, "60daysAgo": {"raw": 1.64334, "fmt": "1.64"}, "90daysAgo": {"raw": 1.46368, "fmt": "1.46"}, "epsTrendCurrency": "USD"}, "epsRevisions": {"upLast7days": {"raw": 0, "fmt": null, "longFmt": "0"}, "upLast30days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast30days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast7Days": {"raw": 1, "fmt": "1", "longFmt": "1"}, "downLast90days": {}, "epsRevisionsCurrency": "USD"}}], "defaultMethodology": "nongaap", "maxAge": 1}, "earningsHistory": {"history": [{"maxAge": 1, "epsActual": {"raw": 0.28511, "fmt": "0.29"}, "epsEstimate": {"raw": 0.33405, "fmt": "0.33"}, "epsDifference": {"raw": -0.05, "fmt": "-0.05"}, "surprisePercent": {"raw": -0.14649999, "fmt": "-14.65%"}, "quarter": {"raw": 1727654400, "fmt": "2024-09-30"}, "currency": "USD", "period": "-4q"}, {"maxAge": 1, "epsActual": {"raw": 0.83506, "fmt": "0.84"}, "epsEstimate": {"raw": 0.27548, "fmt": "0.28"}, "epsDifference": {"raw": 0.56, "fmt": "0.56"}, "surprisePercent": {"raw": 2.0313, "fmt": "203.13%"}, "quarter": {"raw": 1735603200, "fmt": "2024-12-31"}, "currency": "USD", "period": "-3q"}, {"maxAge": 1, "epsActual": {"raw": 0.305, "fmt": "0.31"}, "epsEstimate": {"raw": 0.2274, "fmt": "0.23"}, "epsDifference": {"raw": 0.08, "fmt": "0.08"}, "surprisePercent": {"raw": 0.3412, "fmt": "34.12%"}, "quarter": {"raw": 1743379200, "fmt": "2025-03-31"}, "currency": "USD", "period": "-2q"}, {"maxAge": 1, "epsActual": {"raw": 0.542, "fmt": "0.54"}, "epsEstimate": {"raw": 0.33587, "fmt": "0.34"}, "epsDifference": {"raw": 0.21, "fmt": "0.21"}, "surprisePercent": {"raw": 0.6137, "fmt": "61.37%"}, "quarter": {"raw": 1751241600, "fmt": "2025-06-30"}, "currency": "USD", "period": "-1q"}], "defaultMethodology": "nongaap", "maxAge": 86400}, "financialData": {"maxAge": 86400, "currentPrice": {"raw": 28.71, "fmt": "28.71"}, "targetHighPrice": {"raw": 49.0, "fmt": "49.00"}, "targetLowPrice": {"raw": 27.5, "fmt": "27.50"}, "targetMeanPrice": {"raw": 37.61429, "fmt": "37.61"}, "targetMedianPrice": {"raw": 39.0, "fmt": "39.00"}, "recommendationMean": {"raw": 1.625, "fmt": "1.62"}, "recommendationKey": "buy", "numberOfAnalystOpinions": {"raw": 7, "fmt": "7", "longFmt": "7"}, "totalCash": {"raw": 2899000064, "fmt": "2.9B", "longFmt": "2,899,000,064"}, "totalCashPerShare": {"raw": 47.136, "fmt": "47.14"}, "ebitda": {"raw": 1327422464, "fmt": "1.33B", "longFmt": "1,327,422,464"}, "totalDebt": {"raw": 148000000, "fmt": "148M", "longFmt": "148,000,000"}, "quickRatio": {"raw": 6.196, "fmt": "6.20"}, "currentRatio": {"raw": 6.216, "fmt": "6.22"}, "totalRevenue": {"raw": 3646881280, "fmt": "3.65B", "longFmt": "3,646,881,280"}, "debtToEquity": {"raw": 2.791, "fmt": "2.79%"}, "revenuePerShare": {"raw": 5.7793, "fmt": "5.78"}, "returnOnAssets": {"raw": 0.13262, "fmt": "13.26%"}, "returnOnEquity": {"raw": 0.28117, "fmt": "28.12%"}, "grossProfits": {"raw": 3447810816, "fmt": "3.45B", "longFmt": "3,447,810,816"}, "freeCashflow": {"raw": 770889152, "fmt": "770.89M", "longFmt": "770,889,152"}, "operatingCashflow": {"raw": 1134404096, "fmt": "1.13B", "longFmt": "1,134,404,096"}, "earningsGrowth": {"raw": 0.732, "fmt": "73.20%"}, "revenueGrowth": {"raw": 0.187, "fmt": "18.70%"}, "grossMargins": {"raw": 0.94541, "fmt": "94.54%"}, "ebitdaMargins": {"raw": 0.36398998, "fmt": "36.40%"}, "operatingMargins": {"raw": 0.38919, "fmt": "38.92%"}, "profitMargins": {"raw": 0.37590998, "fmt": "37.59%"}, "financialCurrency": "USD"}}